INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹-7.99 | ₹10.68 | ₹15.44 | ₹16.80 | ₹10.10 |
What is the latest Earnings Per Share (EPS) of INDOCO REMEDIES ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹-7.99 |
| Mar2024 | ₹10.68 |
| Mar2023 | ₹15.44 |
| Mar2022 | ₹16.80 |
| Mar2021 | ₹10.10 |
How is Earnings Per Share (EPS) of INDOCO REMEDIES Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹-7.99 | Negative | |
| Mar2024 | ₹10.68 | -30.83 | |
| Mar2023 | ₹15.44 | -8.10 | |
| Mar2022 | ₹16.80 | 66.34 | |
| Mar2021 | ₹10.10 | - | |
Compare Earnings Per Share (EPS) of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹1,875.5 Cr | -1.1% | -2.3% | -21.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,717.0 Cr | 0.6% | 7% | 1.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,830.0 Cr | 1.6% | 4.6% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,479.0 Cr | 3.1% | 5.9% | 39% | Stock Analytics | |
| CIPLA | ₹108,978.0 Cr | 1.5% | -2.1% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,905.0 Cr | 0.5% | 9.8% | 5.7% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -1.1% |
-2.3% |
-21.3% |
| SENSEX | -0.6% |
0.6% |
9.8% |
You may also like the below Video Courses